| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.4 | 0.02 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |